Current and historical daily PE Ratio for Guanhao Biotech Co Ltd (
SZSE:300238
) from 2011 to Jun 16 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Guanhao Biotech stock (SZSE:300238) PE ratio as of Jun 16 2024 is 105.33.
More Details
Guanhao Biotech Co Ltd (SZSE:300238) PE Ratio (TTM) Chart
Guanhao Biotech Co Ltd (SZSE:300238) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1205
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Guanhao Biotech PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-16 | 105.3 | 2024-04-09 | 116.3 |
| 2024-06-14 | 105.3 | 2024-04-08 | 110.9 |
| 2024-06-13 | 105.0 | 2024-04-03 | 117.7 |
| 2024-06-12 | 106.1 | 2024-04-02 | 119.8 |
| 2024-06-11 | 103.2 | 2024-04-01 | 123.2 |
| 2024-06-07 | 102.9 | 2024-03-29 | 119.3 |
| 2024-06-06 | 100.6 | 2024-03-28 | 118.8 |
| 2024-06-05 | 105.4 | 2024-03-27 | 86.6 |
| 2024-06-04 | 107.6 | 2024-03-26 | 91.4 |
| 2024-06-03 | 108.7 | 2024-03-25 | 95.4 |
| 2024-05-31 | 111.9 | 2024-03-22 | 100.9 |
| 2024-05-30 | 110.4 | 2024-03-21 | 92.7 |
| 2024-05-29 | 111.4 | 2024-03-20 | 93.1 |
| 2024-05-28 | 111.4 | 2024-03-19 | 90.8 |
| 2024-05-27 | 113.6 | 2024-03-18 | 91.6 |
| 2024-05-24 | 114.8 | 2024-03-15 | 89.2 |
| 2024-05-23 | 115.2 | 2024-03-14 | 88.2 |
| 2024-05-22 | 120.7 | 2024-03-13 | 89.4 |
| 2024-05-21 | 119.2 | 2024-03-12 | 91.3 |
| 2024-05-20 | 121.6 | 2024-03-11 | 86.7 |
| 2024-05-17 | 120.7 | 2024-03-08 | 85.8 |
| 2024-05-16 | 121.1 | 2024-03-07 | 83.4 |
| 2024-05-15 | 121.9 | 2024-03-06 | 86.1 |
| 2024-05-14 | 125.2 | 2024-03-05 | 85.4 |
| 2024-05-13 | 126.2 | 2024-03-04 | 89.2 |
| 2024-05-10 | 136.1 | 2024-03-01 | 85.8 |
| 2024-05-09 | 155.3 | 2024-02-29 | 85.4 |
| 2024-05-08 | 142.2 | 2024-02-28 | 83.1 |
| 2024-05-07 | 118.6 | 2024-02-27 | 89.8 |
| 2024-05-06 | 116.6 | 2024-02-26 | 88.3 |
| 2024-04-30 | 113.6 | 2024-02-23 | 84.8 |
| 2024-04-29 | 110.1 | 2024-02-22 | 82.9 |
| 2024-04-26 | 105.8 | 2024-02-21 | 81.3 |
| 2024-04-25 | 103.9 | 2024-02-20 | 78.6 |
| 2024-04-24 | 102.4 | 2024-02-19 | 75.6 |
| 2024-04-23 | 101.1 | 2024-02-08 | 72.8 |
| 2024-04-22 | 99.2 | 2024-02-07 | 65.1 |
| 2024-04-19 | 98.3 | 2024-02-06 | 71.3 |
| 2024-04-18 | 100.1 | 2024-02-05 | 72.0 |
| 2024-04-17 | 102.2 | 2024-02-02 | 82.5 |
| 2024-04-16 | 95.3 | 2024-02-01 | 87.7 |
| 2024-04-15 | 103.7 | 2024-01-31 | 86.0 |
| 2024-04-12 | 109.9 | 2024-01-30 | 93.2 |
| 2024-04-11 | 111.7 | 2024-01-29 | 93.9 |
| 2024-04-10 | 112.1 | 2024-01-26 | 98.8 |
Guanhao Biotech Co Ltd (SZSE:300238) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Guanhao Biotech Co Ltd
NAICS : 339112
ISIN : CNE100001575
Share Class Description:
SZSE:300238: Class ACompare
Compare
Traded in other countries / regions
300238.China IPO Date
2011-07-06Description
Guanhao Biotech Co Ltd is a China-based biotech company. It develops, manufactures and markets life and health-related products, with focus on regenerative medicines for the treatment of damaged tissue and organs. Its products include NormalGEN dura repair patch, GrandNeuro (Type B) dura repair patch, ThromalGEN (Type P) surgical patch, Guanhao-ACI, among others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers